# Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses

> **NCT01170936** · PHASE2 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 10 (actual)

## Conditions studied

- Urticaria
- Vasculitis

## Interventions

- **DRUG:** canakinumab

## Key facts

- **NCT ID:** NCT01170936
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01170936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01170936, "Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01170936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*